InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement

Core Viewpoint - InterCure Ltd. has received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement, as its ordinary shares have been trading below $1.00 for 30 consecutive business days [1][5]. Compliance Period - The company has been granted a 180-calendar day compliance period until August 24, 2026, to regain compliance by ensuring the closing bid price meets or exceeds $1.00 for at least 10 consecutive business days [2][3]. Additional Compliance Options - If compliance is not achieved by the deadline, the company expects to qualify for an additional 180-calendar day compliance period, contingent upon submitting a transfer application and meeting other listing requirements [3]. Strategic Measures - The company plans to monitor its share price and may consider a reverse share split, pending necessary approvals, as part of its strategy to regain compliance [4]. Business Overview - InterCure, operating as Canndoc, is a leading and profitable cannabis company outside North America, recognized as Israel's largest licensed cannabis producer with a high-margin vertically integrated model [6].